Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03675893
Title Abemaciclib With Letrozole in Recurrent or Persistent Endometrial Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute

endometrial cancer


Abemaciclib + Letrozole

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.